北京.2012年7月临床检验新进展讲义之 2012-07-26 鄢盛恺 调脂治疗的靶标:LDL-C、apo B or non-HDL-C?.pptVIP

北京.2012年7月临床检验新进展讲义之 2012-07-26 鄢盛恺 调脂治疗的靶标:LDL-C、apo B or non-HDL-C?.ppt

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
* Key Points There are four major classifications of lipoproteins present in plasma, shown here in order of their size. As just discussed, VLDL is released from the liver into the plasma. IDL and LDL are products of lipolysis (removal of TGs) of VLDL. That is, as VLDL moves through the bloodstream, tissues selectively pull off the TGs (because FAs are energy and tissues need them). As TGs are pulled off, the VLDL particle shrinks, becoming IDL, and then TG removal from IDL converts it into LDL. HDL is the smallest lipoprotein. Instead of taking cholesterol from the liver to other tissues, it picks up cholesterol from these tissues and brings it to steriodogenic tissues, the liver, or the kidneys. That’s why it is considered the “good” cholesterol. VLDL, IDL, and LDL all contain apoB, and together are considered Non-HDL cholesterol. Let’s take a closer look at the transport of TG and cholesterol on these lipoproteins… Thomas Dayspring MD * * Reference: National Institutes of Health.Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary. Bethesda, MD: National Institutes of Health; 2001. NIH Publication No. 01-3670. * Non HDL-C and VLDL-C and Their Risk Predictive Values in CHD. Senior author Scott M. Grundy, chairman of the NCEP ATP III, published this study that analyzed data from the Framingham Heart Study (2693 men and 3101 women) in order to determine if non–HDL-C is a more useful predictor of CHD risk than LDL-C and if VLDL-C is an independent predictor of CHD risk. All patients were aged ≥30 years of age and free of CHD at baseline, and incident CHD was the end point (618 men and 372 women). After multivariate adjustment, within non–HDL-C, no association was found between LDL-C and the risk for incident CHD. In contrast, a strong positive and graded association between non–HDL-C and risk for CHD was observed

文档评论(0)

好文精选 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档